US in-hospital mortality for COVID-19 was almost 14% overall but decreased 15 percentage points from March to August 2020, with higher rates in older patients, according to a research letter published in JAMA Network Open late last week.
Survivors of the first reported outbreak of Ebola still harbor detectable antibodies to the virus 40 years later, and some of those antibodies can still neutralize live virus, researchers reported today in the Journal of Infectious Diseases.
Boston University's National Emerging Infectious Disease Laboratories (NEIDL) received final approval from the Boston Public Health Commission to conduct biosafety level 4 (BSL-4) research, clearing the final hurdle to begin work on some of the world's most lethal pathogens, such as Ebola and Marburg virus, BU Today, the campus newspaper, reported.
England has experienced an unprecedented resurgence in scarlet fever infections that began in 2014, but so far the reasons for the escalation aren't clear, researchers from Public Health England reported yesterday in The Lancet Infectious Diseases.
Tests on a traditional healer in Kenya who was a contact of one of the lab-confirmed Uganda Marburg patients has tested negative, and other high-risk contacts in Kenya have completed their 21-day monitoring periods, with no other illnesses detected, the World Health Organization (WHO) said yesterday.
In an ongoing multistate Cyclospora outbreak, 96 more patients without a history of international travel who were sick on or after May 1 have been reported to the US Centers for Disease Prevention and Control (CDC), boosting the national total to 347, according to the agency's latest update.
Experts made more recommendations about fractional IPV dosing and also discussed issued related to cholera, Ebola, and diphtheria.
